These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7654017)
21. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization. Kosano H; Takatani O Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846 [TBL] [Abstract][Full Text] [Related]
22. Differentiation of HL-60 cells distinguishes between cytostatic and cytotoxic effects of the alkylphospholipid ET-18-OCH3. Civoli F; Pauig SB; Daniel LW Cancer Chemother Pharmacol; 1996; 38(3):269-72. PubMed ID: 8646802 [TBL] [Abstract][Full Text] [Related]
23. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine. Zhou X; Lu X; Arthur G Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233 [TBL] [Abstract][Full Text] [Related]
24. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286 [TBL] [Abstract][Full Text] [Related]
25. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells. Arthur G; Samadder P; Bittman R Anticancer Res; 2005; 25(1A):95-100. PubMed ID: 15816524 [TBL] [Abstract][Full Text] [Related]
26. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities. Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro. Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272 [TBL] [Abstract][Full Text] [Related]
28. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro. Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980 [TBL] [Abstract][Full Text] [Related]
29. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440. Petersen ES; Kelley EE; Modest EJ; Burns CP Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine). Marino-Albernas JR; Bittman R; Peters A; Mayhew E J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506 [TBL] [Abstract][Full Text] [Related]
31. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells. Bazill GW; Dexter TM Cancer Res; 1990 Dec; 50(23):7505-12. PubMed ID: 2253199 [TBL] [Abstract][Full Text] [Related]
32. Effects of ether lipid 1-O-octadecyl-2-methoxy-rac-glycero- 3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes. Cardile V; Jiang X; Renis M; Bindoni M Brain Res; 1996 Apr; 715(1-2):98-103. PubMed ID: 8739627 [TBL] [Abstract][Full Text] [Related]
33. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380 [TBL] [Abstract][Full Text] [Related]
34. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells. Zhou X; Lu X; Richard C; Xiong W; Litchfield DW; Bittman R; Arthur G J Clin Invest; 1996 Aug; 98(4):937-44. PubMed ID: 8770865 [TBL] [Abstract][Full Text] [Related]
35. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells. Noseda A; Berens ME; White JG; Modest EJ Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458 [TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system. Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487 [TBL] [Abstract][Full Text] [Related]
37. Mitochondrial-derived ROS in edelfosine-induced apoptosis in yeasts and tumor cells. Zhang H; Gajate C; Yu LP; Fang YX; Mollinedo F Acta Pharmacol Sin; 2007 Jun; 28(6):888-94. PubMed ID: 17506948 [TBL] [Abstract][Full Text] [Related]
38. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Small GW; Strum JC; Daniel LW Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959 [TBL] [Abstract][Full Text] [Related]
39. Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranes. Torrecillas A; Aroca-Aguilar JD; Aranda FJ; Gajate C; Mollinedo F; Corbalán-García S; de Godos A; Gómez-Fernández JC Int J Pharm; 2006 Aug; 318(1-2):28-40. PubMed ID: 16624506 [TBL] [Abstract][Full Text] [Related]
40. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells. Kosano H; Takatani O J Lipid Mediat; 1990; 2(2):117-21. PubMed ID: 2135668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]